Ampk Alpha is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-protein
{
float: right;
width: 300px;
padding: 10px;
background: #f8f9fa;
border: 1px solid #ddd;
border-radius: 4px;
margin: 10px;
}
.infobox .infobox-protein th
{
background: #28a745;
color: white;
padding: 8px;
}
.infobox .infobox-protein td
{
padding: 6px;
}
|+ **AMPK Alpha**
! Protein Name
| AMPK Alpha
! Gene
| [PRKAA1](/genes/prkaa1)
! UniProt ID
| [Q9NPJ3](https://www.uniprot.org/uniprot/Q9NPJ3)
! PDB IDs
| 4CFE, 4R3C
! Molecular Weight
| 62.3 kDa
! Subcellular Localization
| Cytoplasm
! Protein Family
| AMPK family
AMPK Alpha (PRKAA1) is a protein involved in cellular signaling and molecular processes. It is expressed in various tissues including the brain and plays roles in neuronal function and disease mechanisms.
AMPK has a catalytic kinase domain and regulatory subunits.
AMPK is an energy sensor that activates when cellular ATP is low. It promotes catabolism (glycolysis, fatty acid oxidation) and inhibits anabolism (protein synthesis, lipogenesis). AMPK is activated by exercise and metformin.
AMPK activation is neuroprotective in Alzheimer's, Parkinson's, and Huntington's disease models.
Metformin activates AMPK and is being studied for neuroprotection. AICAR is an AMPK activator used in research.
The study of Ampk Alpha has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Hardie DG (2011) AMPK: a target for drugs. J Clin Invest 121(1):44-52. PMID: 21218081
- Carling D et al. (2012) AMPK: the heat shock response. Nat Rev Mol Cell Biol 13(10):e1. PMID: 22982914
- Salminen A et al. (2016) AMPK in neurodegenerative diseases. J Mol Neurosci 59(3):330-338. PMID: 26868680
- Vingtdeux V et al. (2011) AMPK and Alzheimer's disease. Acta Neuropathol 121(2):175-191. PMID: 20972429
- Greco SJ et al. (2011) AMPK in Parkinson's disease. Exp Neurol 227(2):296-301. PMID: 21145891
- Saavedra LG et al. (2020) AMPK activation and neuroprotection. Neuropharmacology 170:107991. PMID: 32032688
- Wang Y et al. (2012) AMPK and mitochondrial biogenesis. Neurobiol Aging 33(5):1002.e17-1002.e31. PMID: 21450120
- Marinangeli C et al. (2018) AMPK in synaptic plasticity. J Neurochem 147(5):576-599. PMID: 30358099
- Hardie DG (2011) AMPK: a target for drugs. J Clin Invest 121(1):44-52. PMID: 21218081
- Carling D et al. (2012) AMPK: the heat shock response. Nat Rev Mol Cell Biol 13(10):e1. PMID: 22982914
- Salminen A et al. (2016) AMPK in neurodegenerative diseases. J Mol Neurosci 59(3):330-338. PMID: 26868680
- Vingtdeux V et al. (2011) AMPK and Alzheimer's disease. Acta Neuropathol 121(2):175-191. PMID: 20972429
- Greco SJ et al. (2011) AMPK in Parkinson's disease. Exp Neurol 227(2):296-301. PMID: 21145891
- Saavedra LG et al. (2020) AMPK activation and neuroprotection. Neuropharmacology 170:107991. PMID: 32032688
- Wang Y et al. (2012) AMPK and mitochondrial biogenesis. Neurobiol Aging 33(5):1002.e17-1002.e31. PMID: 21450120
- Marinangeli C et al. (2018) AMPK in synaptic plasticity. J Neurochem 147(5):576-599. PMID: 30358099